340B ACCESS Act

The 340B ACCESS Act would amend the Public Health Service Act to reform the 340B drug pricing program by tightening eligibility definitions, increasing oversight, and enhancing transparency requirements for covered entities and their contract pharmacies. It would redefine "patient" to require an ongoing provider-patient relationship and limit eligibility for drugs dispensed via telehealth or through non-covered entity providers, while also targeting duplicate Medicaid discounts and mandating new reporting and data submission rules. The bill affects hospitals, clinics, and other healthcare entities participating in the 340B program, particularly large nonhospital providers and those…

No official summary is available here. This one was written by AI from the bill’s text.